Skip to content
Search

Latest Stories

'Deprived areas of  England witnessed 41% pharmacy closure in last seven year'

The Company Chemists’ Association (CCA)’s research has found that between 2015 and 2022 more than 40 per cent of permanent community pharmacy closures took place in the 20 per cent most deprived parts of England.

The association has analyzed the NHS data and found that between 2015 and 2022, 808 pharmacies closed permanently in England. In that period, only 138 new pharmacies opened – a net loss of 670 community pharmacies.


It also examined where permanent closures had taken place. “41% of net permanent closures had taken place in the top 20% most deprived areas in England. Meanwhile, only 9% of net permanent closures took place in the top 20% least deprived areas.”

Although the latest figures for 2021/22 suggest that the overall rate of closures may be slowing down, the proportion of pharmacies permanently shutting in more deprived areas has only increased.

An even larger share of pharmacies that permanently shut in 2021/22 occurred in the most deprived areas compared with the previous fiscal year: 44% of net closures took place within the bottom two IMD deciles.

Although a national problem, the North and West Midlands were found to have shouldered a heavy burden of closures in most deprived areas. 63% of closures in the most deprived areas were concentrated in the Northwest, West Midlands, and Yorkshire and Humber.

Breakdown of permanent net closures by region in England

Total Net Closures per Region(2015/16 - 2021/22)aTotal Net Closures in

Most Deprived Areas per Region

(2015/16 - 2021/22)b
Proportion of Closures in Deprived Areas (% of Total Closures) per Region(2015/16 - 2021/22)c
North West-132-7859%
South East-101-1111%
West Midlands-91-5864%
London-76-1722%
Yorkshire and The Humber-76-3951%
South West-70-2333%
East of England-42-1536%
East Midlands-41-1332%
North East-39-2051%

The CCA is concerned that permanent closures will undermine healthcare accessibility in deprived areas, where access tends to be more limited despite greater need (the ‘inverse care law’). The reverse is true for community pharmacy – 89.2% of the population is estimated to have access to a community pharmacy within a 20-minute walk, and crucially in areas of highest deprivation access is significantly higher (99.8%) – otherwise known as the ‘positive pharmacy care law’. Moreover, ‘underserved’ communities may be more likely to visit their local pharmacy, according to NICE guidelines.

NHS England has devised ‘Core20PLUS5’, a national and Integrated Care System-level approach to reducing health inequalities in the top 20% most deprived populations by focusing on five areas of clinical focus such as chronic respiratory disease and hypertension case-finding.

Malcolm Harrison, Chief Executive of the CCA said: "Research shows that population health is greatly affected by standards of nutrition, housing, working environment and education.  Therefore, access to healthcare needs to be greater in areas of higher deprivation.  Unfortunately, the opposite is true, with access to general practice often better in more affluent areas. However, we know that there is greater access to community pharmacies in deprived areas.

Pharmacies continue to close disproportionately in areas of deprivation at a concerning rate. Closures will only worsen the health of deprived communities. The CCA is concerned that individuals may not be able to visit pharmacies at all to either get the medicines and advice they need or to be referred into other parts of the system.

The current funding model for community pharmacy is broken. The pharmacy network is no longer economically viable. The Government must face the facts and stop pharmacy closures by providing a sustainable level of funding. Without action, the country is sleepwalking towards an ever-worsening crisis in primary care – which threatens the entire ‘levelling up’ agenda for people in the most deprived communities.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less